TSLP and coronary artery disorder: Previously, a study had demonstrated that CHD suppressed AD symptoms in a DNFB-induced NC/Nga mouse model and inhibited thymic stromal lymphopoietin (TSLP) and inflammatory cytokines by blocking the RIP2/caspase-1 signaling pathway in HMC-1 cells [21].